If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAY.L Regulatory News (CAY)

  • There is currently no data for CAY

Form 8.3 - Charles Stanley Group Plc

2 Aug 2021 15:20

Aberforth Partners LLP - Form 8.3 - Charles Stanley Group Plc

Aberforth Partners LLP - Form 8.3 - Charles Stanley Group Plc

PR Newswire

London, August 2

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Aberforth Partners LLP, on behalf of discretionary clients.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Charles Stanley Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 30/07/2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/A NO If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 4,563,777 8.75% 0 0.0
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 4,563,777 8.75% 0 0.0

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 1,399,602 shares included in the total disclosed above. This total includes 1,399,602 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Ordinary Shares Sale 3,500,000  510.3p

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 02 August 2021
Contact name:Michael Campbell, for Aberforth Partners LLP
Telephone number:0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
29th Jul 201310:24 amRNSAGM Statement
29th Jul 201310:20 amRNSDirector/PDMR Shareholding
26th Jul 20137:00 amRNS1st Quarter Results
11th Jul 201310:04 amRNSAdditional Listing
24th Jun 201311:21 amRNSAnnual Financial Report
11th Jun 20137:00 amRNSFinal Results
4th Jun 20133:32 pmRNSHolding(s) in Company
21st May 20131:09 pmRNSHolding(s) in Company
30th Apr 20131:39 pmRNSTotal Voting Rights
19th Apr 20139:08 amRNSHolding(s) in Company
11th Apr 20137:00 amRNSTrading Statement
5th Apr 201310:37 amRNSAdditional Listing
21st Mar 20139:58 amRNSDirector/PDMR Shareholding
15th Feb 20131:38 pmRNSDirector/PDMR Shareholding
15th Feb 20139:33 amRNSDirector/PDMR Shareholding
25th Jan 20137:00 amRNSInterim Management Statement
16th Jan 20133:18 pmRNSDirectorate Change
9th Jan 20133:29 pmRNSHolding(s) in Company
4th Jan 201310:50 amRNSDirector/PDMR Shareholding
19th Dec 201210:12 amRNSDirector/PDMR Shareholding
5th Dec 20122:05 pmRNSHolding(s) in Company
30th Nov 20129:26 amRNSTotal Voting Rights
16th Nov 20128:44 amRNSAdditional Listing
14th Nov 201212:23 pmRNSHolding in Company
9th Nov 201211:35 amRNSHolding(s) in Company
8th Nov 20127:00 amRNSHalf Yearly Report
22nd Oct 20125:23 pmRNSHolding in Company
11th Oct 20122:27 pmRNSHolding(s) in Company
3rd Oct 201211:56 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSTrading Statement
20th Sep 20129:27 amRNSCompany Secretary Change
3rd Sep 201212:59 pmRNSDirectorate Change
31st Aug 20123:14 pmRNSHolding(s) in Company
27th Jul 20122:40 pmRNSHolding in Company
26th Jul 20124:55 pmRNSResult of AGM
26th Jul 201211:00 amRNSInterim Management Statement
13th Jul 20128:18 amRNSDirectorate Change
3rd Jul 20125:13 pmRNSHolding in Company
29th Jun 201212:14 pmRNSAnnual Information Update
29th Jun 20129:06 amRNSAnnual Financial Report
21st Jun 20125:15 pmRNSHolding in Company
14th Jun 20127:00 amRNSFinal Results
14th May 201210:20 amRNSHolding(s) in Company
8th May 20129:37 amRNSHolding(s) in Company
23rd Apr 201211:06 amRNSTR-1: Notification of Major Interest in Shares
12th Apr 201211:21 amRNSDirector/PDMR Shareholding
5th Apr 201211:59 amRNSDirector/PDMR Shareholding
4th Apr 20122:49 pmRNSHolding(s) in Company
8th Feb 20127:00 amRNSAppointment of Joint Corporate Broker
25th Jan 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.